Page last updated: 2024-10-31

fidexaban and Coronary Thrombosis

fidexaban has been researched along with Coronary Thrombosis in 2 studies

Fidexaban: structure in first source

Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
" However, five of six animals given the lowest effective dosage of rTAP and four of six animals given DX-9065a bled from a surgical incision >5 min, but only two of six animals given ZK-807834 bled >5 min."1.31Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits. ( Abendschein, DR; Baum, PK; Eisenberg, PR; Light, DR; Martin, DJ; Post, J; Rumennik, G; Sullivan, ME; Vergona, R, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abendschein, DR2
Baum, PK2
Martin, DJ1
Vergona, R1
Post, J1
Rumennik, G1
Sullivan, ME2
Eisenberg, PR2
Light, DR2
Verhallen, P1

Other Studies

2 other studies available for fidexaban and Coronary Thrombosis

ArticleYear
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:5

    Topics: Amidines; Animals; Anticoagulants; Antithrombin III; Arthropod Proteins; Coronary Thrombosis; Diseas

2000
A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:2

    Topics: Amidines; Animals; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Blood Coagul

2001